We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
One More Step to Finalize Your Registration
An activation link has been sent to your email address.
Please check the email and activate your account now. It might take few minutes to get the email.
If you did not find it, please check your spam box.
Having problem receiving the email? Send again
Still cannot receive? Contact us
Email :PharmaSources@imsinoexpo.com
Whatsapp :+86-13621645194
Main Sales Markets: North America,Central/South America,Western Europe,Eastern Europe,Australasia,Asia,Middle East
Monthly Production Capacity: 100kg
Packaging Information: 1kg/bottle
Sample Provided: yes
Payment Terms: L/L
Product Information
Product name
Alprostadil
Molecular Formula
C20H34O5
Molecular Weight
354.48
CAS No.
745-65-3
Quality Standard
95% up, USP26
Appearance
White powder
COA of Alprostadil
Items
Specifications
Results
Appearance
White to off-white powder
Complies
Identification
HPLC retention time of sample complies with that of known sample
Complies
Water
≤0.5%
0.03%
Residual solvents
≤0.5%
0.02%
Residual on ignition
≤0.5%
0.20%
Related substances
PGAI:≤0.5%
Undetected
PGBI:≤0.5%
Undetected
13,14-Dihydro-PGEI: ≤0.5%
Undetected
Other impurities: ≤ 0.5%
Undetected
Assay
95.0%~105.0%
99.00%
Usage
Function of Alprostadil Alprostadil, alias PGE1. PGE1 is a biologically active substance widely present in the body, the mechanism of treating diabetic neuropathy:
1. Improve hemodynamics, increase the CAMP content in vascular smooth muscle cells, exert its vasodilator effect and reduce peripheral resistance;
2. To improve blood rheology, PGE can inhibit platelet aggregation, reduce platelet high response and thromboxane A (TXA) level, inhibit platelet activation, promote the reversal of activated platelets around thrombus, and improve the deformability of red blood cells;
3. PGE can activate lipoproteinase and promote triglyceride hydrolysis, reduce blood lipids and blood viscosity;
4. PGE can stimulate vascular endothelial cells to produce tissue-type fibrinolytic substance (t-PA), which has a certain direct thrombolytic effect.
5. By inhibiting free Caz of vascular smooth muscle cells and inhibiting the release of norepinephrine from vascular sympathetic nerve endings, the vascular smooth muscle is relaxed and the microcirculation is improved.